Funian Lu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Ovarian cancer diagnosis and treatment
Papers in ⓘ
-
- Endometrial and Cervical Cancer Treatments 2
- Co-authors
- Gang Chen (11 shared papers)Rourou Xiao (11 shared papers)Bin Yang (8 shared papers)Xianda Zhao (4 shared papers)Ensong Guo (6 shared papers)Chen Zhao (4 shared papers)Honglei Chen (4 shared papers)Lixin You (3 shared papers)
- Journals
- Aging (2 papers)Microbial Ecology (1 paper)British Journal of Cancer (1 paper)Oncology Reports (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Funian Lu
18 papers receiving 357 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 76
- Reproductive Medicine 37
- Oncology 117
- Obstetrics and Gynecology 24
- Molecular Biology 197
Countries citing papers authored by Funian Lu
This map shows the geographic impact of Funian Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Funian Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Funian Lu more than expected).
Fields of papers citing papers by Funian Lu
This network shows the impact of papers produced by Funian Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Funian Lu. The network helps show where Funian Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Funian Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 68 | |
| 2 | 2021 | 38 | |
| 3 | 2006 | 33 | |
| 4 | Dysregulation of JAM-A plays an important role in human tumor progression. | 2014 | 33 |
| 5 | 2016 | 26 | |
| 6 | 2017 | 23 | |
| 7 | 2021 | 20 | |
| 8 | 2018 | 18 | |
| 9 | 2022 | 17 | |
| 10 | 2021 | 17 | |
| 11 | 2022 | 15 | |
| 12 | mTOR inhibition overcomes primary and acquired resistance to Wee1 inhibition by augmenting replication stress in epithelial ovarian cancers. | 2020 | 14 |
| 13 | 1999 | 12 | |
| 14 | 2024 | 8 | |
| 15 | 2021 | 7 | |
| 16 | 2023 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2021 | 3 | |
| 19 | 2025 | 0 |
About Funian Lu
Funian Lu is a scholar working on Structural Biology, Obstetrics and Gynecology, Oncology, Reproductive Medicine and Microbiology, having authored 19 papers that have together received 359 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (4 papers), Ovarian cancer diagnosis and treatment (3 papers), MicroRNA in disease regulation (2 papers), Renal and related cancers (2 papers), Endometrial and Cervical Cancer Treatments (2 papers), Cancer Cells and Metastasis (2 papers), CAR-T cell therapy research (2 papers) and Gut microbiota and health (2 papers). The work is most often cited by research in Cancer Research (76 citations), Reproductive Medicine (37 citations), Oncology (117 citations), Obstetrics and Gynecology (24 citations) and Molecular Biology (197 citations). Funian Lu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Gang Chen, Rourou Xiao, Bin Yang, Xianda Zhao, Ensong Guo, Chen Zhao, Honglei Chen, Lixin You, Zhenkun Wang and Chaoyang Sun. Their work appears in journals such as Aging, Microbial Ecology, British Journal of Cancer, Oncology Reports and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.